Psoriasis and Metabolic Comorbidities: The Importance of Well-Designed Prospective Studies
Explore this paper's citation graph
Summary
The study shows that Psoriasis patients when they were first ever diagnosed of having psoriasis did not have an increased prevalence of hyperlipidemia, diabetes, hypertension or any other medical conditions, and a higher proportion of psoriatic patients were overweight or obese when they was first diagnosed to be affected with psor dermatological patients.
- Type
- article
- Published
- 2008-07-25
- Cited by
- 9
- References
- 24
- OpenAlex
- https://openalex.org/W18663303
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:12160759
Keywords
Appeal, Product (mathematics), Business, Process (computing), Service (business)
References
- Psoriasis is associated with lipid abnormalities at the onset of skin disease.
- Medical History, Drug Exposure and the Risk of Psoriasis
- Inflammation and metabolic disorders
- The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study.
- Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis.
- Mechanisms of Disease: atherosclerosis in autoimmune diseases
- Risk of myocardial infarction in patients with psoriasis.
- Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks
- Heart disease in psoriasis.
- Metabolic disorders in patients with psoriasis and psoriatic arthritis
- Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients
- Prevalence of metabolic syndrome in patients with psoriasis: a hospital‐based case–control study
- Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study.
- Psoriasis: a possible risk factor for development of coronary artery calcification
- Adipocytokines: mediators linking adipose tissue, inflammation and immunity
- Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients.
- Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus.
- Impact of obesity and smoking on psoriasis presentation and management.
- Plasma homocysteine and folate levels in patients with chronic plaque psoriasis
- Prevalence of cardiovascular risk factors in patients with psoriasis.
Cited by
- C-Reactive Protein and Markers for Thrombophilia in Patients with Chronic Plaque Psoriasis
- Vitamin D status in psoriasis patients treated with UVB therapy
- Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies
- Efficacy of Efalizumab in Psoriasis Patients Previously Treated with Tumour Necrosis Factor Blockers
- Treatment of Psoriasis with Efalizumab in Patients with Hepatitis C Viral Infection: Report of Five Cases
- Psoriatic arthritis and risk of overt cardiovascular disease: review of the evidence
- Glutathione peroxidase activity in the blood cells of psoriatic patients correlates with their responsiveness to Efalizumab
- 8 UVB and Vitamin D in Psoriasis
- UVB and Vitamin D in Psoriasis
Related papers
- Gas utility executives' forum. [Recommendations]
- Big users: U. S. hinders alternate energy growth
- Ahead of Schedule, Under Budget, and Out of Court
- Right-Sized Reuse - Use a Systematic Process, and Design for a Specialized, Yet Flexible Result - 13558
- Does Competitive Sourcing Really Pay
- The Government and the Private Sector - a Shotgun Wedding or an Inevitable Relationship?
- TWO SIDES TO A CONSULTANT
- Third Party Contract Issues Concerning Motor Carriers, Brokers, and Shippers